AstraZeneca (AZN) News Today £111.80 -136.00 (-1.20%) As of 06:23 AM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesSustainabilityBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period AstraZeneca announces results presented at ELCC on TagrissoMarch 26 at 5:41 AM | markets.businessinsider.comAstraZeneca slips Monday, underperforms marketMarch 24 at 1:48 PM | marketwatch.comPrediction: 12 months from now, AstraZeneca’s share price could be…March 24 at 8:47 AM | msn.comAnalysts Set AstraZeneca PLC (LON:AZN) PT at GBX 7,542.80March 24 at 2:41 AM | americanbankingnews.comAstraZeneca investing $2.5 billion in China as drugmaker seeks to recover from scandalsMarch 22, 2025 | msn.comAstraZeneca to invest $2.5B in Beijing R&D and manufacturingMarch 21, 2025 | markets.businessinsider.comPharma Stock Roundup: PFE's Final Haleon Stake Sale, AZN, SNY M&A DealsMarch 21, 2025 | msn.comAstraZeneca PLC (LON:AZN) Given Average Rating of "Moderate Buy" by AnalystsAstraZeneca PLC (LON:AZN - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the seven brokerages that are presently covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to thMarch 21, 2025 | marketbeat.comHere’s Why Parnassus Growth Equity Fund Decided to Sell AstraZeneca PLC (AZN)March 20, 2025 | msn.comAdyen and AstraZeneca gain TD Cowen’s Best Ideas recognition on growth potentialMarch 19, 2025 | investing.com£10,000 invested in AstraZeneca shares 1 year ago is now worth…March 19, 2025 | msn.comIs AstraZeneca (AZN) the Best European Stock to Buy According to Billionaires?March 18, 2025 | msn.comAstraZeneca to acquire biotech firm at cost of up to $1BMarch 17, 2025 | bizjournals.comAstraZeneca Strikes up to $1 Billion Deal to Buy EsoBiotecMarch 17, 2025 | msn.comEuropean stocks rise on German debt deal hopes; AstraZeneca in focusMarch 17, 2025 | investing.comAstraZeneca (AZN) Gets a Buy from UBSMarch 17, 2025 | markets.businessinsider.comEventful Monday For AstraZeneca - What's Going On?March 17, 2025 | benzinga.comAstraZeneca to buy EsoBiotec for up to $1 billionMarch 17, 2025 | msn.comAstraZeneca (LON:AZN) Stock Crosses Above 200 Day Moving Average - What's Next?AstraZeneca (LON:AZN) Share Price Crosses Above 200-Day Moving Average - Should You Sell?March 15, 2025 | marketbeat.comWhy Is CRISPR Therapeutics (CRSP) Up 0.4% Since Last Earnings Report?March 13, 2025 | finance.yahoo.comIONS/AZN Get FDA Nod for Amyloidosis Drug, Wainzua in EuropeMarch 11, 2025 | msn.comAstraZeneca announces MATTERHORN trial resultsMarch 7, 2025 | markets.businessinsider.comAstraZeneca (LON:AZN) Receives "Buy" Rating from Shore CapitalShore Capital restated a "buy" rating on shares of AstraZeneca in a research note on Friday.March 7, 2025 | marketbeat.comAstrazeneca (AZN) Stock Moves -0.63%: What You Should KnowMarch 7, 2025 | msn.comAstraZeneca (LON:AZN) Stock Price Crosses Above Two Hundred Day Moving Average - What's Next?AstraZeneca (LON:AZN) Stock Crosses Above Two Hundred Day Moving Average - Here's WhyMarch 4, 2025 | marketbeat.comDaiichi Sankyo and AstraZeneca report positive result in trial for its gastric cancer treatmentMarch 3, 2025 | msn.comIs AstraZeneca PLC (AZN) the Best Weight Loss Drug Stock to Buy According to Analysts?March 1, 2025 | msn.comAstraZeneca's metastatic breast cancer treatment gets EU recommendationFebruary 28, 2025 | msn.comAstraZeneca Enhertu recommended for approval in EU by CHMPFebruary 28, 2025 | markets.businessinsider.comAstraZeneca, Daiichi Sankyo’s Enhertu recommended for approval in EUFebruary 28, 2025 | markets.businessinsider.comBerenberg Bank Sticks to Its Buy Rating for AstraZeneca (AZN)February 27, 2025 | markets.businessinsider.comAstraZeneca reports SERENA-6 trial shows improvement in the primary endpointFebruary 27, 2025 | markets.businessinsider.comAstraZeneca PLC (LON:AZN) Receives Average Recommendation of "Moderate Buy" from BrokeragesShares of AstraZeneca PLC (LON:AZN - Get Free Report) have earned an average rating of "Moderate Buy" from the seven ratings firms that are presently covering the company, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation and five have given a buy recommendFebruary 24, 2025 | marketbeat.comFINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZenecaFebruary 21, 2025 | tmcnet.comAstraZeneca PLC (AZN): Among the Best Global Stocks to Buy According to Hedge FundsFebruary 20, 2025 | msn.comJPMorgan Chase & Co. Reaffirms Overweight Rating for AstraZeneca (LON:AZN)JPMorgan Chase & Co. restated an "overweight" rating on shares of AstraZeneca in a report on Wednesday.February 20, 2025 | marketbeat.comAstraZeneca (LON:AZN) Stock Crosses Above 200 Day Moving Average - Time to Sell?AstraZeneca (LON:AZN) Stock Price Crosses Above Two Hundred Day Moving Average - Should You Sell?February 15, 2025 | marketbeat.comAstraZeneca reports positive results for Imfinzi MIBC regimenFebruary 15, 2025 | msn.comAZN Lawsuit Alert! Class Action Against AstraZeneca Plc.February 14, 2025 | markets.businessinsider.comPositive Report for AstraZeneca (AZN) from UBSFebruary 13, 2025 | markets.businessinsider.comDown 13% from its year high at £116.50 now, AstraZeneca’s share price looks cheap to me anywhere under £219.81February 12, 2025 | fool.co.ukAstraZeneca initiated with an Overweight at Morgan StanleyFebruary 12, 2025 | markets.businessinsider.comAstraZeneca (AZN) Gets a Buy from BernsteinFebruary 11, 2025 | markets.businessinsider.com4AZN : Unpacking the Latest Options Trading Trends in AstraZenecaFebruary 11, 2025 | benzinga.comGoldman Sachs cuts AstraZeneca stock price target to GBP150.67February 10, 2025 | msn.comAstraZeneca (LON:AZN) Stock Passes Above Two Hundred Day Moving Average - Here's What HappenedAstraZeneca (LON:AZN) Stock Crosses Above 200-Day Moving Average - Here's WhyFebruary 7, 2025 | marketbeat.comAstraZeneca (AZN) Gets a Hold from UBSFebruary 6, 2025 | markets.businessinsider.comAstraZeneca Plc (AZN) Q4 2024 Earnings Call TranscriptFebruary 6, 2025 | msn.comAstraZeneca (AZN) Gets a Buy from BarclaysFebruary 5, 2025 | markets.businessinsider.comU.K. defends negotiations with AstraZeneca, BBC News reportsFebruary 4, 2025 | markets.businessinsider.com Remove Ads Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address AZN Media Mentions By Week AZN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AZN News Sentiment▼0.470.79▲Average Medical News Sentiment AZN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AZN Articles This Week▼113▲AZN Articles Average Week Remove Ads Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GSK News Ithaca Energy News HUTCHMED News Grainger News Indivior News Bloomsbury Publishing News Origin Enterprises News Global Ports News India Capital Growth News Alpha Real Trust News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:AZN) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredThis Crypto Is Set to Explode in FebruaryBryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
